Suppr超能文献

择期开胸手术患者 tube thoracostomy 术后抗菌预防以预防感染性并发症的双盲、安慰剂对照、随机试验。

Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thoracic surgery: a double-blind, placebo-controlled, randomized trial.

机构信息

Divisions of Infectious Diseases, Brigham and Women’s Hospital, Boston, Massachusetts, USA.

出版信息

JAMA Surg. 2013 May;148(5):440-6. doi: 10.1001/jamasurg.2013.1372.

Abstract

OBJECTIVE

To determine whether extended postoperative antibacterial prophylaxis for patients undergoing elective thoracic surgery with tube thoracostomy reduces the risk of infectious complications compared with preoperative prophylaxis only.

DESIGN

Prospective, randomized, double-blind, placebo-controlled trial.

SETTING

Brigham and Women's Hospital, an 800-bed tertiary care teaching hospital in Boston, Massachusetts.

PARTICIPANTS

A total of 251 adult patients undergoing elective thoracic surgery requiring tube thoracostomy between April 2008 and April 2011.

INTERVENTIONS

Patients received preoperative antibacterial prophylaxis with cefazolin sodium (or other drug if the patient was allergic to cefazolin). Postoperatively, patients were randomly assigned (at a 1:1 ratio) using a computer-generated randomization sequence to receive extended antibacterial prophylaxis (n = 125) or placebo (n = 126) for 48 hours or until all thoracostomy tubes were removed, whichever came first.

MAIN OUTCOME MEASURES

The combined occurrence of surgical site infection, empyema, pneumonia, and Clostridium difficile colitis by postoperative day 28.

RESULTS

A total of 245 patients were included in the modified intention-to-treat analysis (121 in the intervention group and 124 in the placebo group). Thirteen patients (10.7%) in the intervention group and 8 patients (6.5%) in the placebo group had a primary end point (risk difference, -4.3% [95% CI, -11.3% to 2.7%]; P = .26). Six patients (5.0%) in the intervention group and 5 patients (4.0%) in the placebo group developed surgical site infections (risk difference, -0.93% [95% CI, -6.1% to 4.3%]; P = .77). Seven patients (5.8%) in the intervention group and 3 patients (2.4%) in the placebo group developed pneumonia (risk difference, -3.4% [95% CI, -8.3% to 1.6%]; P = .21). One patient in the intervention group developed empyema. No patients experienced C difficile colitis.

CONCLUSIONS

Extended postoperative antibacterial prophylaxis for patients undergoing elective thoracic surgery requiring tube thoracostomy did not reduce the number of infectious complications compared with preoperative prophylaxis only.

TRIAL REGISTRATION

clinicaltrials.gov Identifier: NCT00818766.

摘要

目的

确定与仅术前预防相比,对接受胸腔管引流的择期开胸手术患者进行延长术后抗菌预防是否降低感染并发症的风险。

设计

前瞻性、随机、双盲、安慰剂对照试验。

地点

马萨诸塞州波士顿的布里格姆妇女医院,一家拥有 800 张床位的三级护理教学医院。

参与者

2008 年 4 月至 2011 年 4 月期间接受择期开胸手术且需要胸腔管引流的 251 例成年患者。

干预措施

患者接受头孢唑林钠术前抗菌预防(如果患者对头孢唑林过敏,则使用其他药物)。术后,患者使用计算机生成的随机序列以 1:1 的比例随机分配(n = 125)接受延长抗菌预防(n = 126)48 小时或直至所有胸腔管被移除,以先到者为准。

主要结局测量指标

术后第 28 天发生手术部位感染、脓胸、肺炎和艰难梭菌结肠炎的综合发生率。

结果

共有 245 例患者纳入意向治疗的改良分析(干预组 121 例,安慰剂组 124 例)。干预组 13 例(10.7%)和安慰剂组 8 例(6.5%)患者出现主要终点(风险差异,-4.3%[95%CI,-11.3%至 2.7%];P =.26)。干预组 6 例(5.0%)和安慰剂组 5 例(4.0%)患者发生手术部位感染(风险差异,-0.93%[95%CI,-6.1%至 4.3%];P =.77)。干预组 7 例(5.8%)和安慰剂组 3 例(2.4%)患者发生肺炎(风险差异,-3.4%[95%CI,-8.3%至 1.6%];P =.21)。干预组 1 例患者发生脓胸。没有患者发生艰难梭菌结肠炎。

结论

与仅术前预防相比,对接受胸腔管引流的择期开胸手术患者进行延长术后抗菌预防并不能降低感染并发症的数量。

试验注册

clinicaltrials.gov 标识符:NCT00818766。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验